Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.78)
# 594
Out of 5,108 analysts
680
Total ratings
46.6%
Success rate
15.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Reiterated: Buy | $55 → $51 | $25.87 | +97.14% | 6 | Nov 5, 2026 | |
| RLAY Relay Therapeutics | Initiated Coverage: Buy | $26 | $17.00 | +52.94% | 1 | Oct 27, 2026 | |
| EDIT Editas Medicine | Upgraded: Buy | $5 | $2.55 | +96.08% | 2 | Sep 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $106 → $86 | $56.12 | +53.24% | 9 | Sep 17, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $89 → $80 | $38.80 | +106.19% | 14 | Sep 14, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $40 → $44 | $32.53 | +35.26% | 4 | Sep 9, 2026 | |
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $50 | $15.48 | +223.00% | 1 | Aug 18, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $123 → $104 | $42.71 | +143.50% | 2 | Aug 17, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $69 → $81 | $25.65 | +215.79% | 4 | Aug 11, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $43 → $35 | $15.57 | +124.79% | 6 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32.14 | $9.02 | +256.33% | 4 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $38.87 | +31.21% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $11 | $3.64 | +202.20% | 5 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.64 | - | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.10 | - | 7 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.46 | - | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.32 | +201.72% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $4.55 | +273.63% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.01 | +299.50% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.72 | +1,179.07% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $9.87 | +92.50% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $18.89 | +138.22% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $300.25 | -5.41% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $6.18 | +320.71% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $32.53 | +78.30% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $2.91 | n/a | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $95 | $21.01 | n/a | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $17.57 | n/a | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $5 | $4.45 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 → $546 | $542.50 | n/a | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $17.36 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $48.56 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.66 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $24 | $4.09 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.114 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $9.20 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.22 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $26.07 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 2.62 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $33.56 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $30 | $8.85 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $19.42 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.26 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.09 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.48 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $1.85 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $28.74 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $2.22 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $36.15 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $14.19 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $28.27 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $71.63 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $1.5 | $0.624 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $16.49 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 | $65.67 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.1895 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $9.36 | n/a | 13 | Aug 14, 2015 |
Beam Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $55 → $51
Current: $25.87
Upside: +97.14%
Relay Therapeutics
Oct 27, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $17.00
Upside: +52.94%
Editas Medicine
Sep 23, 2026
Upgraded: Buy
Price Target: $5
Current: $2.55
Upside: +96.08%
BioMarin Pharmaceutical
Sep 17, 2026
Reiterated: Buy
Price Target: $106 → $86
Current: $56.12
Upside: +53.24%
Ionis Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $89 → $80
Current: $38.80
Upside: +106.19%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $32.53
Upside: +35.26%
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $15.48
Upside: +223.00%
Spruce Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $123 → $104
Current: $42.71
Upside: +143.50%
Neurogene
Aug 11, 2026
Reiterated: Buy
Price Target: $69 → $81
Current: $25.65
Upside: +215.79%
Ultragenyx Pharmaceutical
Aug 3, 2026
Reiterated: Buy
Price Target: $43 → $35
Current: $15.57
Upside: +124.79%
Jul 9, 2026
Reiterated: Buy
Price Target: $32.14
Current: $9.02
Upside: +256.33%
Jul 6, 2026
Reiterated: Buy
Price Target: $51
Current: $38.87
Upside: +31.21%
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $3.64
Upside: +202.20%
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $8.64
Upside: -
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $11.10
Upside: -
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.46
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.32
Upside: +201.72%
Jun 5, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $4.55
Upside: +273.63%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.01
Upside: +299.50%
Jun 2, 2026
Reiterated: Buy
Price Target: $22
Current: $1.72
Upside: +1,179.07%
May 28, 2026
Reiterated: Buy
Price Target: $19
Current: $9.87
Upside: +92.50%
May 7, 2026
Reiterated: Buy
Price Target: $45
Current: $18.89
Upside: +138.22%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $300.25
Upside: -5.41%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $6.18
Upside: +320.71%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $32.53
Upside: +78.30%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $2.91
Upside: n/a
Sep 24, 2025
Reiterated: Buy
Price Target: $28 → $95
Current: $21.01
Upside: n/a
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $17.57
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $5
Current: $4.45
Upside: n/a
Aug 6, 2025
Reiterated: Buy
Price Target: $450 → $546
Current: $542.50
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $45 → $50
Current: $17.36
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $48.56
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $156.66
Upside: n/a
Apr 5, 2022
Reiterated: Buy
Price Target: $28 → $24
Current: $4.09
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.114
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $9.20
Upside: n/a
Sep 1, 2020
Reiterated: Buy
Price Target: $20
Current: $3.22
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $26.07
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 2.62
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $33.56
Upside: n/a
Aug 11, 2020
Reiterated: Buy
Price Target: $36 → $30
Current: $8.85
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $19.42
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.26
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.09
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $3.48
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $1.85
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $54
Current: $28.74
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $2.22
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $36.15
Upside: n/a
Dec 18, 2019
Reiterated: Buy
Price Target: $2
Current: $14.19
Upside: n/a
Aug 1, 2017
Reiterated: Hold
Price Target: n/a
Current: $28.27
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $71.63
Upside: n/a
Oct 20, 2016
Reiterated: Hold
Price Target: $9 → $1.5
Current: $0.624
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $16.49
Upside: n/a
Oct 16, 2015
Reiterated: Hold
Price Target: $63
Current: $65.67
Upside: n/a
Aug 16, 2015
Reiterated: Buy
Price Target: $4
Current: $0.1895
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $9.36
Upside: n/a